. Gαi1 and Gαi3 double knockout abolishes VEGF-induced Akt-mTORC1 and Erk activation in mouse embryonic fibroblasts. (A-D) The wild-type (WT) or Gi1 and Gi3 double knockout (DKO) mouse embryonic fibroblasts (MEFs) were treated with VEGF ("-A", at applied concentration for indicate time), and were tested by Western blotting assay of listed proteins. For all the Western blotting assay, each lane was loaded with exact same amount of quantified protein lysates (30 μg per treatment). *P< 0.05.
. Knockdown of Gi1/3 inhibits VEGF-induced Akt-mTORC1 and Erk activation in mouse embryonic fibroblasts. (A) WT mouse embryonic fibroblasts (MEFs) were transfected with 100 nM of scramble control siRNA (scr-siRNA), Gi1 or Gi3 siRNA (24 hours per round, 2 rounds), cells were then treated with VEGF ("-A", 25 ng/mL) for indicated time, and were tested by Western blotting assay of listed proteins. (B) The puromycin-selected stable MEFs, expressing Gi1 and Gi3 shRNA or the scramble control shRNA ("scr-shRNA"), were treated with VEGF ("-A", 25 ng/mL) for indicated time, and were tested by Western blotting assay of listed proteins. (C) WT MEFs were pretreated overnight with pertussis toxin (PTX, 100 ng/mL), followed by indicated VEGF treatment, listed proteins were tested. *P< 0.05 vs. "scr-siRNA" (A).*P< 0.05 vs. "scr-shRNA" (B).
# P< 0.05 (A). 
